Trial intelligence / Profile preview

Sevoflurane rescue after failed intranasal dexmedetomidine sedation for pediatric MRI

ChiCTR2000031153Phase 4Not yet recruiting

Sponsor
Children's Hospital of Chongqing Medical University
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of sevoflurane and dexmedetomidine, sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: MOAA/S score and Aldrete score. Planned start Mar 2020; status: not yet recruiting.

02

Drugs

sevofluranedexmedetomidine

Beyond the preview

Go deeper on ChiCTR2000031153.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000031153.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call